Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Whole Blood Coagulation Time | 3 | 2006 | 29 | 0.490 |
Why?
|
| Blood Coagulation Tests | 5 | 2005 | 263 | 0.470 |
Why?
|
| Hirudins | 2 | 2005 | 179 | 0.290 |
Why?
|
| Prothrombin Time | 3 | 2007 | 116 | 0.250 |
Why?
|
| Anticoagulants | 6 | 2006 | 4862 | 0.230 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2005 | 1090 | 0.220 |
Why?
|
| Monitoring, Ambulatory | 1 | 2000 | 357 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2188 | 0.130 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5127 | 0.130 |
Why?
|
| Warfarin | 1 | 2004 | 1494 | 0.120 |
Why?
|
| Heparin | 4 | 2004 | 1631 | 0.120 |
Why?
|
| Protamines | 3 | 2004 | 110 | 0.120 |
Why?
|
| Point-of-Care Systems | 7 | 2007 | 1216 | 0.120 |
Why?
|
| Heparin Antagonists | 2 | 2004 | 34 | 0.110 |
Why?
|
| Diltiazem | 1 | 1993 | 132 | 0.100 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2004 | 198 | 0.100 |
Why?
|
| Vitamin K | 2 | 2007 | 312 | 0.090 |
Why?
|
| Platelet Aggregation | 1 | 1993 | 770 | 0.090 |
Why?
|
| Blood Coagulation | 5 | 2005 | 1167 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 1999 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 6489 | 0.060 |
Why?
|
| Computers, Handheld | 2 | 2004 | 211 | 0.060 |
Why?
|
| Food-Drug Interactions | 1 | 2004 | 26 | 0.060 |
Why?
|
| Enoxaparin | 1 | 2006 | 390 | 0.050 |
Why?
|
| International Normalized Ratio | 2 | 2007 | 381 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2004 | 3673 | 0.050 |
Why?
|
| Blood Platelets | 1 | 1993 | 2464 | 0.050 |
Why?
|
| Drug Monitoring | 2 | 2006 | 960 | 0.050 |
Why?
|
| Self Care | 1 | 2007 | 800 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2006 | 1727 | 0.050 |
Why?
|
| Aspirin | 1 | 1993 | 3135 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1993 | 2771 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 423 | 0.050 |
Why?
|
| Factor V | 1 | 2000 | 168 | 0.040 |
Why?
|
| Automation | 1 | 1999 | 585 | 0.030 |
Why?
|
| Reference Standards | 1 | 2000 | 1013 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2005 | 2082 | 0.030 |
Why?
|
| Phenobarbital | 1 | 1995 | 192 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1794 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5302 | 0.030 |
Why?
|
| Bleeding Time | 1 | 1993 | 83 | 0.030 |
Why?
|
| Factor VIII | 1 | 1996 | 347 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1993 | 142 | 0.030 |
Why?
|
| Hemostatics | 1 | 1995 | 247 | 0.030 |
Why?
|
| Thrombin Time | 2 | 2005 | 7 | 0.030 |
Why?
|
| Hemophilia A | 1 | 1996 | 357 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1993 | 419 | 0.020 |
Why?
|
| Equipment Design | 1 | 2000 | 3488 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 430 | 0.020 |
Why?
|
| Epinephrine | 1 | 1993 | 782 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1993 | 1751 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1995 | 1364 | 0.020 |
Why?
|
| Prenatal Care | 1 | 1995 | 1157 | 0.020 |
Why?
|
| Humans | 16 | 2007 | 765823 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1995 | 2120 | 0.020 |
Why?
|
| Quality of Life | 1 | 2007 | 13466 | 0.020 |
Why?
|
| Hirudin Therapy | 1 | 2005 | 43 | 0.020 |
Why?
|
| Germany | 1 | 2007 | 882 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 2 | 1996 | 202 | 0.020 |
Why?
|
| Research Design | 1 | 2000 | 6207 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40109 | 0.010 |
Why?
|
| Alabama | 1 | 2003 | 111 | 0.010 |
Why?
|
| Autoanalysis | 1 | 2002 | 70 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 20131 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2003 | 312 | 0.010 |
Why?
|
| Activated Protein C Resistance | 1 | 2000 | 18 | 0.010 |
Why?
|
| Software | 2 | 2004 | 4458 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2007 | 59506 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 11506 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 2331 | 0.010 |
Why?
|
| Adult | 6 | 2007 | 223055 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15794 | 0.010 |
Why?
|
| Biological Assay | 1 | 1999 | 627 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2003 | 1029 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3474 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 1590 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 2795 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2002 | 2169 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 1999 | 14644 | 0.010 |
Why?
|
| Algorithms | 2 | 2007 | 14062 | 0.010 |
Why?
|
| Male | 5 | 2007 | 363740 | 0.010 |
Why?
|
| Aged | 4 | 2007 | 171178 | 0.010 |
Why?
|
| Female | 5 | 2007 | 396050 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6061 | 0.010 |
Why?
|
| Middle Aged | 4 | 2007 | 223016 | 0.010 |
Why?
|
| Observer Variation | 1 | 1996 | 2611 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 4911 | 0.000 |
Why?
|
| Gestational Age | 1 | 1995 | 3614 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1995 | 12421 | 0.000 |
Why?
|
| Incidence | 1 | 2000 | 21501 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2000 | 41643 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1995 | 26337 | 0.000 |
Why?
|
| United States | 1 | 2002 | 72896 | 0.000 |
Why?
|
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_